Annual ROE
-68.16%
+30.00%+30.56%
December 31, 2023
Summary
- As of February 8, 2025, COCP annual return on equity is -68.16%, with the most recent change of +30.00% (+30.56%) on December 31, 2023.
- During the last 3 years, COCP annual ROE has fallen by -43.49% (-176.29%).
- COCP annual ROE is now -130.64% below its all-time high of 222.46%, reached on December 31, 2012.
Performance
COCP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-94.62%
-20.73%-28.06%
September 30, 2024
Summary
- As of February 8, 2025, COCP quarterly return on equity is -94.62%, with the most recent change of -20.73% (-28.06%) on September 30, 2024.
- Over the past year, COCP quarterly ROE has dropped by -42.99% (-83.27%).
- COCP quarterly ROE is now -102.46% below its all-time high of 3849.73%, reached on September 30, 2011.
Performance
COCP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
COCP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.6% | -83.3% |
| 3 y3 years | -176.3% | -25.7% |
| 5 y5 years | -19.7% | -25.7% |
COCP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -272.7% | +30.6% | -392.6% | +0.5% |
| 5 y | 5-year | -272.7% | +34.5% | -433.1% | +24.3% |
| alltime | all time | -130.6% | +34.5% | -102.5% | +79.7% |
Cocrystal Pharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -94.62%(+28.1%) |
| Jun 2024 | - | -73.89%(+26.1%) |
| Mar 2024 | - | -58.60%(+3.0%) |
| Dec 2023 | -68.16%(-30.6%) | -56.90%(+10.2%) |
| Sep 2023 | - | -51.63%(+0.9%) |
| Jun 2023 | - | -51.18%(-46.2%) |
| Mar 2023 | - | -95.07%(+26.3%) |
| Dec 2022 | -98.16%(+436.7%) | -75.25%(+20.9%) |
| Sep 2022 | - | -62.22%(+20.8%) |
| Jun 2022 | - | -51.52%(+160.7%) |
| Mar 2022 | - | -19.76%(+2.9%) |
| Dec 2021 | -18.29%(-25.9%) | -19.21%(+8.2%) |
| Sep 2021 | - | -17.75%(-0.9%) |
| Jun 2021 | - | -17.91%(-17.4%) |
| Mar 2021 | - | -21.68%(-7.5%) |
| Dec 2020 | -24.67%(-76.3%) | -23.43%(-81.2%) |
| Sep 2020 | - | -124.94%(+11.7%) |
| Jun 2020 | - | -111.85%(+19.2%) |
| Mar 2020 | - | -93.83%(+20.6%) |
| Dec 2019 | -104.04%(+82.7%) | -77.80%(+37.7%) |
| Sep 2019 | - | -56.50%(+10.4%) |
| Jun 2019 | - | -51.18%(+7.7%) |
| Mar 2019 | - | -47.53%(-3.1%) |
| Dec 2018 | -56.94%(+9550.8%) | -49.05%(<-9900.0%) |
| Sep 2018 | - | 0.41%(+925.0%) |
| Jun 2018 | - | 0.04%(-89.2%) |
| Mar 2018 | - | 0.37%(-161.7%) |
| Dec 2017 | -0.59%(-98.9%) | -0.60%(-99.0%) |
| Sep 2017 | - | -62.54%(+12.3%) |
| Jun 2017 | - | -55.70%(+7.2%) |
| Mar 2017 | - | -51.97%(+7.4%) |
| Dec 2016 | -55.48% | -48.37%(+112.3%) |
| Sep 2016 | - | -22.78%(+7.0%) |
| Jun 2016 | - | -21.29%(+4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | -20.45%(-38.3%) |
| Dec 2015 | -57.53%(+3761.1%) | -33.14%(+82.0%) |
| Sep 2015 | - | -18.21%(-38.0%) |
| Jun 2015 | - | -29.39%(-26.5%) |
| Mar 2015 | - | -40.01%(+371.8%) |
| Dec 2014 | -1.49%(-103.4%) | -8.48%(-98.2%) |
| Sep 2014 | - | -465.06%(+595.4%) |
| Jun 2014 | - | -66.88%(-239.3%) |
| Mar 2014 | - | 48.01%(-8.4%) |
| Dec 2013 | 44.01%(-80.2%) | 52.43%(-51.5%) |
| Sep 2013 | - | 108.17%(-33.4%) |
| Jun 2013 | - | 162.40%(-4.5%) |
| Mar 2013 | - | 170.10%(-28.7%) |
| Dec 2012 | 222.46%(+12.9%) | 238.60%(+18.6%) |
| Sep 2012 | - | 201.11%(-27.0%) |
| Jun 2012 | - | 275.43%(-32.9%) |
| Mar 2012 | - | 410.28%(-46.4%) |
| Dec 2011 | 197.08%(+263.1%) | 765.60%(-80.1%) |
| Sep 2011 | - | 3849.73%(+83.3%) |
| Jun 2011 | - | 2100.35%(+574.2%) |
| Mar 2011 | - | 311.55%(-6.8%) |
| Dec 2010 | 54.28%(-174.9%) | 334.43%(-54.5%) |
| Sep 2010 | - | 734.31%(+908.3%) |
| Jun 2010 | - | 72.83%(-266.7%) |
| Mar 2010 | - | -43.69%(-26.6%) |
| Dec 2009 | -72.50%(+32.5%) | -59.53%(+20.4%) |
| Sep 2009 | - | -49.45%(+4.6%) |
| Jun 2009 | - | -47.26%(-4.8%) |
| Mar 2009 | - | -49.66%(+3.7%) |
| Dec 2008 | -54.71%(+37.7%) | -47.87%(-28.9%) |
| Sep 2008 | - | -67.33%(-2.3%) |
| Jun 2008 | - | -68.93%(+26.7%) |
| Mar 2008 | - | -54.40%(+49.7%) |
| Dec 2007 | -39.72% | -36.33% |
FAQ
- What is Cocrystal Pharma annual return on equity?
- What is the all time high annual ROE for Cocrystal Pharma?
- What is Cocrystal Pharma annual ROE year-on-year change?
- What is Cocrystal Pharma quarterly return on equity?
- What is the all time high quarterly ROE for Cocrystal Pharma?
- What is Cocrystal Pharma quarterly ROE year-on-year change?
What is Cocrystal Pharma annual return on equity?
The current annual ROE of COCP is -68.16%
What is the all time high annual ROE for Cocrystal Pharma?
Cocrystal Pharma all-time high annual return on equity is 222.46%
What is Cocrystal Pharma annual ROE year-on-year change?
Over the past year, COCP annual return on equity has changed by +30.00% (+30.56%)
What is Cocrystal Pharma quarterly return on equity?
The current quarterly ROE of COCP is -94.62%
What is the all time high quarterly ROE for Cocrystal Pharma?
Cocrystal Pharma all-time high quarterly return on equity is 3849.73%
What is Cocrystal Pharma quarterly ROE year-on-year change?
Over the past year, COCP quarterly return on equity has changed by -42.99% (-83.27%)